Human Whole Genome Sequencing 
Human whole genome sequencing  (hWGS) enables researchers to catalog a genetic constitution of individuals and capture all variants present in a single assay. It is utilized to study cancer and a variety of diseases, as well as human population evolution studies and pharmacogenomics. 
Equipped with the powerful Illumina NovaSeq 6000 system, Novogene is capable of sequencing up to 280,000 human genomes per year at the lowest cost per genome. With extensive experience in whole genome sequencing and advanced bioinformatics capabilities, Novogene is able to expertly meet customer needs for delivering large project results with quick turnaround times and the highest quality results.
Novogene Advantage

  • Scalable Sequencing Capacity  
  • Industry-Leading Data Quality Guarantee (Q30 > 85%)
  • Competitive Pricing
  • Extensive In-House Bioinformatics Expertise
Project Workflow
Sequencing Specifications

Sample Requirements
  • DNA Amount: ≥ 200 ng (gDNA from fresh tissues); ≥ 0.8 μg (gDNA from FFPE)
  • DNA Concentration: ≥ 10 ng/μL
  • Purity: OD 260/280 = 1.8-2.0; no degradation and no contamination (RNA or protein)
Sequencing Strategy
  • 350 bp insert DNA library                    
  • NovaSeq 6000 platform, PE150
Recommended Sequencing Depth
  • For tumor tissues: 50×, adjacent normal tissues and blood 30×
  • For rare diseases: 30-50×
Turnaround Time
  • 11 working days after verification of sample quality without data analysis (depending on sample size)
Analysis Pipeline
* Detailed items on advanced analysis to suit your project are available. Please contact us for more information.
Novogene Powered Publications
Human Whole Exome Sequencing 
Exome sequencing provides a cost-effective alternative to whole genome sequencing, as it targets only the protein coding region of the human genome responsible for a majority of known disease-related variants. Whether you are conducting studies in rare mendelian disorders, complex disease, cancer research, or human population studies, Novogene’s comprehensive human whole exome sequencing (hWES) service provides a high-quality, affordable, and convenient solution. 
Advantages of hWES

Targeted Protein Coding Region:
by capturing and sequencing protein coding region, hWES is utilized to reveal variants related to protein structure
High Accuracy: 
with high sequencing depth, hWES facilitates detection of common variants and rare variants with frequencies lower than 1%
Cost Effective:
hWES yields approximately 85% of human disease mutations from 1% of human genome
Project Workflow
Sequencing Specifications

Exome Capture
  • Agilent SureSelect Human All Exon V6 Kit 
Sequencing Strategy
  • NovaSeq 6000 platform, PE150
Sample Requirements
  • DNA Amount: ≥ 400 ng (gDNA from fresh tissues); ≥ 0.8 μg (gDNA from FFPE)
  • DNA Concentration: ≥ 20 ng/μL
  • Purity: D260/280 = 1.8-2.0; no degradation and no contamination (RNA or protein)
Recommended Sequencing Depth
  • For Mendelian disorders/rare diseases: effective sequencing depth above 50×
  • For tumor samples: effective sequencing depth above 100×
Turnaround Time
  • Within 13 working days after verification of sample quality without data analysis (depending on sample size)
Analysis Pipeline
* Detailed items on advanced analysis to suit your project are available. Please contact us for more information.
Novogene Powered Publications

Novogene Corporation Inc.

8801 Folsom Blvd #290, Sacramento, CA 95826

916-252-0068-383     inquiry_us@novogene.com     en.novogene.com

Copyright©2011-2021 Novogene Corporation
All Rights Reserved. Information and specifications are subject to change at any time without notice.